Last updated: 6 July 2019 at 1:55am EST

Carol A Gamble Net Worth




The estimated Net Worth of Carol A Gamble is at least $6.94 Million dollars as of 9 March 2012. Carol Gamble owns over 50,000 units of Jazz Pharmaceuticals plc stock worth over $3,386,553 and over the last 17 years Carol sold JAZZ stock worth over $3,549,477.

Carol Gamble JAZZ stock SEC Form 4 insiders trading

Carol has made over 6 trades of the Jazz Pharmaceuticals plc stock since 2009, according to the Form 4 filled with the SEC. Most recently Carol sold 50,000 units of JAZZ stock worth $2,478,000 on 9 March 2012.

The largest trade Carol's ever made was exercising 205,261 units of Jazz Pharmaceuticals plc stock on 11 January 2012 worth over $3,635,172. On average, Carol trades about 18,650 units every 48 days since 2007. As of 9 March 2012 Carol still owns at least 32,213 units of Jazz Pharmaceuticals plc stock.

You can see the complete history of Carol Gamble stock trades at the bottom of the page.



What's Carol Gamble's mailing address?

Carol's mailing address filed with the SEC is C/O JAZZ PHARMACEUTICALS, INC., 3180 PORTER DRIVE, PALO ALTO, CA, 94304.

Insiders trading at Jazz Pharmaceuticals plc

Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright, and Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.



What does Jazz Pharmaceuticals plc do?

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni



Complete history of Carol Gamble stock trades at Jazz Pharmaceuticals plc

Insider
Trans.
Transaction
Total value
Carol A Gamble
SVP, GC, and Corporate Secty
Sale $2,478,000
9 Mar 2012
Carol A Gamble
SVP, GC, and Corporate Secty
Option $3,635,172
11 Jan 2012
Carol A Gamble
SVP, GC, and Corporate Secty
Option $139,500
3 Dec 2010
Carol A Gamble
SVP, GC, and Corporate Secty
Sale $873,929
18 Nov 2010
Carol A Gamble
SVP, GC, and Corporate Secty
Sale $165,068
8 Mar 2010
Carol A Gamble
SVP, GC, and Corporate Secty
Sale $32,480
8 Sep 2009


Jazz Pharmaceuticals plc executives and stock owners

Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: